Is the Amerlex free-thyroxine assay a useful screening test in the elderly?

Area of Science:

• Endocrinology
• Geriatric Medicine
• Clinical Chemistry

Background:

• Thyroid function tests are essential in diagnosing thyroid disorders.
• Elderly patients, particularly those who are acutely ill, present unique challenges in interpreting thyroid function tests.
• The Amersham Amerlex FT4 assay is a widely used method for measuring free thyroxine levels.

Purpose of the Study:

• To evaluate the utility of the Amersham Amerlex FT4 assay in screening acutely-ill elderly patients.
• To identify common causes of abnormal thyroid function test results in this specific patient group.
• To emphasize the need for confirmatory diagnostic approaches.

Main Methods:

• Screening of 1140 acutely-ill elderly patients.
• Utilizing the Amersham Amerlex FT4 assay for thyroid hormone level measurement.
• Analysis of results to identify patterns and causes of abnormalities.

Main Results:

• Nonthyroidal illness (NTI) was identified as the most frequent reason for abnormal free thyroxine (FT4) assay results.
• A significant proportion of abnormal results in this cohort were attributable to NTI rather than primary thyroid dysfunction.
• The study highlights the prevalence of NTI in acutely-ill elderly patients affecting thyroid hormone levels.

Conclusions:

• The Amersham Amerlex FT4 assay screening in acutely-ill elderly patients frequently yields abnormal results due to nonthyroidal illness.
• Confirmatory testing is critically important to differentiate NTI from true thyroid dysfunction in elderly patients.
• Clinical interpretation of FT4 results in acutely-ill elderly individuals must consider the high likelihood of NTI.